Roper Technologies Inc (ROP) stock analysis
Close on Nov 11, 2026Market cap $47.24BP/E 18.9Yield 0.71%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid20 of 30 checks passed
Roper Technologies passes 20 of the 30 checks behind our score; 1 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 6/6
- Growth
- 4/6
- Past performance
- 3/6
- Financial health
- 4/6
- Dividend
- 3/6
What stands out
Margin of safety over 20%
The price is 24.2% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $477.70 is below our fair value estimate of $630.57.
Earnings grew over 5 years
Net income grew 10.1% a year on average over the last five fiscal years.
Revenue growing 10%+ a year
Revenue grew 13.7% a year over the last three fiscal years.
What to watch
Return on equity under 15%
Return on equity was 13.2% over the last twelve months and averaged 13.6% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 7.0%, below the 10% that usually covers the cost of capital.
High debt
Debt is 50.7% of shareholders' equity, above the 40% we consider low.
EPS growing under 10% a year
Diluted EPS grew -30.6% a year over the last three fiscal years.
Valuation6/6
P/E below its 5-year median
Roper Technologies's P/E of 18.9 is below its own 5-year median of 25.6.
P/E below the industry
Roper Technologies's P/E of 18.9 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.
EV/EBITDA below its 5-year median
Roper Technologies's EV/EBITDA of 23.9 is below its 5-year median of 35.1.
P/B below the industry
Roper Technologies's price-to-book of 2.46 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.
Trading below fair value
The share price of $477.70 is below our fair value estimate of $630.57.
Margin of safety over 20%
The price is 24.2% below fair value, more than the 20% cushion we look for.
Growth4/6
Revenue growing 10%+ a year
Revenue grew 13.7% a year over the last three fiscal years.
EPS growing under 10% a year
Diluted EPS grew -30.6% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 65.0% over the last twelve months, against a 5-year average of 10.1% a year.
Growing faster than the industry
Revenue grew 9.2% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.
Guidance lowered
Roper Technologies lowered its full year organic revenue growth outlook on Jul 23, 2026.
Gross margin improving
Gross margin was 69.7% over the last twelve months, against 69.0% a year earlier.
Past performance3/6
Return on equity under 15%
Return on equity was 13.2% over the last twelve months and averaged 13.6% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 7.0%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Roper Technologies's return on equity of 13.2% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.
Earnings grew over 5 years
Net income grew 10.1% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 30.7% over the last twelve months, against a 5-year average of 34.5%.
Net margin above the industry
Roper Technologies's net margin of 30.7% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.
Financial health4/6
High debt
Debt is 50.7% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 91.2% five years ago to 50.7%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 27.0% of total debt.
Interest well covered
Operating income covers interest expense 5.8 times.
Short-term assets don't cover short-term debts
Current assets are 0.43 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.03; above 3 is the safe zone and below 1.8 the distress zone.
Dividend3/6
Pays a dividend
Roper Technologies paid dividends worth 0.8% of the share price over the last twelve months.
Yield below Treasuries
The 0.8% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Roper Technologies yields 0.8%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Covered by earnings
Dividends take 14.3% of net income.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$630.57
The share price is 24% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 31.0× | 25.6× | 36.5× | $785.45 | 40% |
| EV/EBITDA | 29.5× | 35.1× | 23.7× | $610.00 | 35% |
| P/B | 3.2× | 3.2× | 3.2× | $616.27 | 10% |
| Earnings power | 8.5% cost of equity | – | – | $275.11 | 15% |
| Fair value | $630.57 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 25.6
- Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $436.33M
- Value traded per 1% price move
- $231.55M
Downside
Medium risk
- Typical loss in a bad month
- 20.7%
- Volatility (annualized)
- 32%
- Sharpe ratio, 1 year
- 0.06
- Beta to the S&P 500 (5Y)
- 0.73
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +12.3% | +13.7% | +14.5% | +8.2% | |
| Gross profit | +12.2% | +13.4% | +14.1% | +9.7% | |
| Operating income | +11.9% | +13.6% | +15.6% | +8.1% | |
| Net income | -0.8% | -30.3% | +10.1% | +8.2% | |
| EPS, diluted | -1.0% | -30.6% | +9.6% | +7.6% | |
| Dividend per share | +10.1% | +10.1% | +10.1% | +12.4% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 11.9% | 9.5% | 7.9% | |
| Return on assets | 5.4% | 4.5% | 4.7% | |
| Current ratio | 1.23 | 0.72 | 0.52 | |
| Debt to equity | 1.07 | 0.91 | 0.47 | |
| Net debt to EBITDA | 4.21× | 5.88× | 2.87× | |
| Interest coverage | 9.4× | 5.0× | 6.9× | |
| Inventory turnover | 7.8× | 6.6× | 18.5× | |
| Capex to revenue | 1.0% | – | – | |
| Diluted shares | 103M | 106M | 108M |
Cash use needs five years of cash flow figures
Roper Technologies does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 19.4% | 0.24× | 1.70× | 7.9% |
| FY2024 | 22.0% | 0.24× | 1.64× | 8.5% |
| FY2023 | 22.4% | 0.22× | 1.65× | 8.3% |
| FY2022 | 84.6% | 0.21× | 1.84× | 32.9% |
| FY2021 | 23.8% | 0.20× | 2.17× | 10.5% |
| FY2020 | 23.6% | 0.19× | 2.11× | 9.5% |
| FY2019 | 37.4% | 0.28× | 1.94× | 20.5% |
| FY2018 | 18.2% | 0.35× | 2.02× | 12.9% |
| FY2017 | 21.1% | 0.32× | 2.26× | 15.4% |
| FY2016 | 17.4% | 0.31× | 2.21× | 11.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$1.54B
- Cash generatingOperating cash flow above zero$2.54B
- Return on assets improvedROA up on the prior year5.5% → 4.9%
- Earnings backed by cashOperating cash flow above net income$2.54B vs $1.54B
- Less leverageLong-term debt to assets fell21.0% → 24.9%
- Better liquidityCurrent ratio rose0.40 → 0.52
- No dilutionShare count did not rise108M → 108M
- Gross margin improvedGross margin up on the prior year69.30% → 69.24%
- More efficientAsset turnover rose0.25 → 0.25
See a number that looks wrong?